P Jenner|C D Marsden|C J Pycock - JoVE Visualize

Showing results (201-210 of 946) with videos related to

Pageof 95

Sort By:

European Journal of Pharmacology|August 25, 1992

Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal gangliaM D Taylor, M L De Ceballos, S Rose, et al.

British Journal of Pharmacology|August 1, 1988

The interaction of substituted benzamides with brain benzodiazepine binding sites in vitroR W Horton, S Lowther, J Chivers, et al.

Neuropharmacology|June 1, 1984

Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to ratsK Murugaiah, S Fleminger, M D Hall, et al.

Brain : a Journal of Neurology|September 1, 1977

Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepamD Chadwick, M Hallett, R Harris, et al.

Journal of Neural Transmission|January 1, 1987

Alterations in cerebral glutamic acid decarboxylase and 3H-flunitrazepam binding during continuous treatment of rats for up to 1 year with haloperidol, sulpiride or clozapineN M Rupniak, S A Prestwich, R W Horton, et al.

Psychopharmacology|April 2, 1999

Actions of the D1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosetsR K Pearce, M Jackson, D R Britton, et al.

European Journal of Pharmacology|September 30, 1983

Elevation of circulating prolactin concentrations may not cause striatal dopamine receptor supersensitivityN Rupniak, M Hong, S Mansfield, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1977

Plasma DOPA levels and growth hormone response to levodopa in parkinsomismA Galea-Debono, P Jenner, C D Marsden, et al.

European Journal of Pharmacology|November 19, 1981

Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatmentP Jenner, N M Rupniak, M D Hall, et al.

Neuropharmacology|November 1, 1989

Treatment with a selective MAO B inhibitor prevents loss of dopamine in the nucleus accumbens of MPTP-treated common marmosetsS Rose, M Nomoto, E A Jackson, et al.

Pageof 95

Showing results (201-210 of 946) with videos related to

Sort By:

Pageof 95

European Journal of Pharmacology|August 25, 1992

Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal gangliaM D Taylor, M L De Ceballos, S Rose, et al.

British Journal of Pharmacology|August 1, 1988

The interaction of substituted benzamides with brain benzodiazepine binding sites in vitroR W Horton, S Lowther, J Chivers, et al.

Neuropharmacology|June 1, 1984

Alterations in different populations of striatal dopamine receptors produced by 18 months continuous administration of cis- or trans-flupenthixol to ratsK Murugaiah, S Fleminger, M D Hall, et al.

Brain : a Journal of Neurology|September 1, 1977

Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepamD Chadwick, M Hallett, R Harris, et al.

Journal of Neural Transmission|January 1, 1987

Alterations in cerebral glutamic acid decarboxylase and 3H-flunitrazepam binding during continuous treatment of rats for up to 1 year with haloperidol, sulpiride or clozapineN M Rupniak, S A Prestwich, R W Horton, et al.

Psychopharmacology|April 2, 1999

Actions of the D1 agonists A-77636 and A-86929 on locomotion and dyskinesia in MPTP-treated L-dopa-primed common marmosetsR K Pearce, M Jackson, D R Britton, et al.

European Journal of Pharmacology|September 30, 1983

Elevation of circulating prolactin concentrations may not cause striatal dopamine receptor supersensitivityN Rupniak, M Hong, S Mansfield, et al.

Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1977

Plasma DOPA levels and growth hormone response to levodopa in parkinsomismA Galea-Debono, P Jenner, C D Marsden, et al.

European Journal of Pharmacology|November 19, 1981

Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatmentP Jenner, N M Rupniak, M D Hall, et al.

Neuropharmacology|November 1, 1989

Treatment with a selective MAO B inhibitor prevents loss of dopamine in the nucleus accumbens of MPTP-treated common marmosetsS Rose, M Nomoto, E A Jackson, et al.

Pageof 95